Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: Cresco - The Real Truth

3 Buy-Rated Cannabis Stocks Under $10 to Scoop Up Now

These three buy-rated cannabis stocks could be set to benefit as both leading presidential candidates show growing support for legalization.

Barchart

2 Magnificent Growth Stocks to Buy Under $30 and Hold Forever

Even a small investment in great stocks could yield significant long-term returns.

Barchart

2 Growth Stocks With 64% to 152% Upside in 2024

These two stocks have been quietly making strides and could be long-term winners.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

2 'Strong Buy' Cannabis Stocks Set to Gain on Spending Bill Maneuvers

The U.S. cannabis market could be on the cusp of a critical growth catalyst, presenting ripe investment opportunities for those ready to navigate its unique risks.

Barchart

Cresco vs. Tilray: Which Cannabis Stock Is a Better Buy?

Despite lingering regulatory challenges, the cannabis market is well-positioned for a steady expansion. Penny stock Cresco's solid financials and growth potential have won over analysts, while Tilray failed to impress with last quarter’s record revenue.

Barchart

2 Growth Stocks With 32% to 77% Upside in 2024

While AI stocks are the center of attention right now, many other growth stocks in various industries are going unnoticed. These stocks may benefit investors in the long run.

Barchart

3 Cannabis Stocks Under $5 to Consider as the DEA Reviews Drug Status

As the DEA reviews the federal classification of marijuana, here's what investors need to know about these three cannabis stocks under $5.

Barchart

Read news from The Economist, FT, and more,
with one subscription

2 Growth Stocks With 35% to 150% Upside in 2024

While all eyes are on AI stocks, there are a few undervalued growth stocks that have the potential to provide investors with massive long-term returns.

Barchart

3 Cannabis Stocks Analysts Like Better Than Canopy Growth

Discover three cannabis stocks with significant growth potential, and learn why analysts favor these names over Canopy Growth.

Barchart

Weed giants Columbia Care, Cresco Labs call off plans for $2 billion merger

Cresco Labs and Columbia Care announced Monday the termination of a merger that was originally struck in 2022.

Chicago Sun-Times

Chicago weed giant Cresco Labs claims in suit that competitor GTI poached a top-level employee

A lawsuit filed this week in Cook County court claims a Cresco chemist resigned in May and quickly joined GTI, in violation of a one-year non-compete agreement.

Chicago Sun-Times

Sean ‘Diddy’ Combs to buy Chicago-area cannabis operations in deal connected to $2 billion Cresco-Columbia Care merger

Sean “Diddy” Combs has agreed to buy nine cannabis retail stores and three production facilities in Illinois, New York and Massachusetts for $185 million as part of required antitrust divestitures for the pending $2 billion Cresco-Columbia Care megamerger.

Chicago Tribune

Cresco Labs Gains 'Firm Visibility' With Recent Asset Sales To Sean Diddy Combs

Cresco Labs Inc (OTCMKTS: CRLBF) and Columbia Care Inc (OTCMKTS: CCHWF) announced the signing of definitive agreements to divest certain New York, Illinois, and Massachusetts assets to an entity owned and controlled by

Benzinga

Sean ‘Diddy’ Combs to gain stake in cannabis trade

The music and fashion mogul will acquire stores in Chicago and Villa Park and a growing operation in Aurora in a deal with Cresco Labs and Columbia Care.

Chicago Sun-Times

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Sean 'Diddy' To Buy Cannabis Assets From Cresco & Columbia Care, Creating The Largest Minority-Owned MSO

Cresco Labs (OTCQX: CRLBF) (CSE:CL) and Columbia Care (OTCQX: CCHWF) (NEO:CCHW) (CSE:CCHW) announced the signing of definitive agreements to divest certain New York, Illinois, and Massachusetts

Chicago Tribune

A pastry chef and chemist combine talents to become a force in cannabis market through edibles

CHICAGO — Award-winning Chicago pastry chef Mindy Segal can be viewed as a modern-day David, using a slingshot loaded with edibles infused with THC to slay the Goliath that is the pain and discomfort of a list of ailments including cancer and multiple sclerosis ... to name a few.

Benzinga

Cresco Labs Anticipates NYC's Massive Cannabis Demand With Strategic Move In Hudson Valley

Cresco Labs (OTC: CRLBF) is redeveloping a former knife factory in Ulster County (two and a half hours from NYC), into a cannabis complex.

Benzinga

What's Going On With Cannabis Pricing In Illinois? Analyst Examines Retailers' Menus

Illinois is one of the most prominent cannabis markets in the U.S. In 2022, recreational marijuana sales crossed the $1 billion mark.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Another Marijuana Firm Dumps A NY Cannabis Deal: Analyst Reveals Future Acquisition Targets And Their M&A Outlook

Just days after Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) notified Goodness Growth Holdings, Inc. (CSE:GDNS) (OTCQX: GDNSF

Benzinga

Columbia Care: Updated Estimates Ahead Of Acquisition By Cresco Labs

The Analyst

Benzinga

Where To Buy Legal Weed These Days: New Cannabis Shops & Products

Curaleaf Bolsters PA Retail Footprint Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) is expanding its Pennsylvaniaretail footprint with a new store in Allentown.

Benzinga

Cannabis Industry Report: House Brands Losing Ground in Massachusetts?

As recreational markets mature, “house brands” are starting to lose share. What is the importance of branded cannabis flowers in this context? What are the macro trends that drive the evolution of the flower category? How does market segmentation impact this category and how do regulations affect market share across states?

Benzinga

'One Of Best-In-Class' Cannabis MSOs Has 'Optionality' When States Go Recreational, Bullish Analyst Says After Results

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) reported its financial results on Wednesday for the second quarter of fiscal 2022, revealing a 4% year-ove

Benzinga

Cannabis Chart of the Week: Is The SAFE+ Act Scaring Away The Shorts?

Cannabis stocks have rallied over the last several weeks as discussion of the Schumer/Booker bill and the likelihood of a pivot to a SAFE+ Banking Act dominated the news. Articles in the press have made it seem as though short sellers had been vigorously covering their positions.

Benzinga

How To Get In Touch With The 5 Biggest Cannabis Operators In The US

While there’s no doubt that the federal legalization of marijuana would make the industry explode, current trends shouldn’t be underestimated.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.